Yukio Fujisawa

Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.

S. Hinuma, S. Kuroda, Y. Fujisawa, 1993, Vaccine.